Amnioinfusion and Meconium-Stained Amniotic Fluid
Author Information
Author(s): C.D. Adair, J.W. Weeks, G. Johnson, S. Burlison, S. London, D.F. Lewis
Primary Institution: Louisiana State University Medical Center
Hypothesis
Does intrapartum amnioinfusion reduce infectious morbidity in patients with meconium-stained fluid?
Conclusion
Amnioinfusion does not provide any benefit in reducing infectious morbidity for patients with meconium-stained amniotic fluid.
Supporting Evidence
- 273 medical records of patients with meconium-stained fluid were studied.
- 129 patients received amnioinfusion, while 144 did not.
- Incidences of intraamniotic infection were 18.6% in the AI group and 24.3% in the non-AI group.
- Postpartum endometritis occurred in 22.5% of AI patients and 21.5% of non-AI patients.
Takeaway
The study looked at whether a treatment called amnioinfusion helps pregnant women with meconium-stained fluid avoid infections, but it found that it doesn't help.
Methodology
A retrospective cohort study reviewing medical records of patients with meconium-stained fluid over one year.
Potential Biases
Possible biases due to the retrospective nature of the study.
Limitations
The study design is retrospective, which may introduce bias.
Participant Demographics
Patients included were those with meconium-stained fluid who delivered at a specific medical center.
Statistical Information
P-Value
0.13 for IAI, 0.97 for PPE
Statistical Significance
p=0.13 for IAI, p=0.97 for PPE
Want to read the original?
Access the complete publication on the publisher's website